| Date | Event |
|---|---|
| March 30, 2026 | Board of Directors for the approval of the draft financial statements for the year ended 31 December 2025. |
| April 30, 2026 | Ordinary Shareholders’ Meeting for the approval of the financial statements for the year ended 31 December 2025 |
| September 29, 2026 | Board of Directors for the approval of the half-year financial report as of 30 June 2026 |
